BMY $66.72 0.06 (0.1%)

    BMY Profile

    BMY trades on the NYSE.

    MEMBERSHIP
    S&P 500




    Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

    BMY Earnings


    Q3 Earnings for Jul, Aug & Sep

    Thu, Oct 31, 2019

    Since Earnings Report

    BMY +17.3%


    Q4 Earnings for Oct, Nov & Dec

    Thu, Feb 6, 2020

    BMY Dividend

    Dividend Yield

    2.70%

    Dividend Rate

    $1.80


    Ex-Dividend Date

    Thu, Jan 2, 2020


    Dividend Pay Date

    Mon, Feb 3, 2020



    Dividend Payments

    137 Payments


    BMY Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Novo Nordisk A/S
    Amgen
    Eli Lilly
    AbbVie
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene

    BIOTECH & PHARMA



    Symbol MC DY Price Day YTD
    BMY $156.08 2.70% $66.72 -0.1% 5.3%






        TOP    




    info@symbolsurfing.com


    Stock Market Terms

    Remove Blur With Premium Subscription

    Symbol Surfing

    ©2020 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy